You searched for - Page 363 of 6563 - KFF Health News

Closed Illinois Hospital Will Be Reopened By OSF Healthcare

January 30, 2024 Morning Briefing

The hospital in Peru, Illinois had been recently shuttered and will now open April 7, offering emergency services and a limited inpatient facility. Also in the news: Steward Health Care’s financial issues; ProMedica’s Paramount Health acquisition by Medical Mutual; and more.

Analysts Expect Medicare To Press Industry For Steep Drug Price Cuts

January 30, 2024 Morning Briefing

The Medicare program’s first ever price negotiations are set to begin, with experts expecting pressure for deep cuts on 10 high-cost medicines. Meanwhile, in Europe regulators are promoting their successes in regulating big pharma.

First Amendment Case On Covid Misinfo Control Heads To Supreme Court

January 30, 2024 Morning Briefing

The lawsuit, which will be heard in March, centers on questions around the federal government’s role in requesting that tech giants suppress covid misinformation during the pandemic. Also, HHS Secretary Xavier Becerra defended federal covid isolation guidelines that California has deviated from.

Using Alcohol, Drugs As A Teen Linked To Psychiatric Distress

January 30, 2024 Morning Briefing

New research published Monday in JAMA Pediatrics found that teens who use cannabis, alcohol, and nicotine are more likely to have underlying mental symptoms. Separate research shows that college students suffering discrimination are more likely to report mental health challenges.

Possible Shot Contamination Linked To Five Early Alzheimer’s Cases

January 30, 2024 Morning Briefing

Five people in the U.K. may have developed Alzheimer’s because of contaminated human growth hormone injections they received as children, a new study suggests. Meanwhile, reports say new Alzheimer’s drugs are bringing hope to some patients, but not equally.

Morning Briefing for Tuesday, January 30, 2024

January 30, 2024 Morning Briefing

Primary care shortages, mifepristone, drug prices, brain implant trial, hospital closings, mental health, misinfo, and more are in the news.

Mifepristone Supreme Court Case Will Be Heard On March 26

January 30, 2024 Morning Briefing

The Supreme Court has scheduled arguments for March 26 in a closely watched case over access to mifepristone, one of two drugs used most commonly in the U.S. for a medication abortion. Issues of FDA authority are also at stake in the lawsuit.

Neuralink’s First Human Brain Implant Trial Gets Underway

January 30, 2024 Morning Briefing

The patient received the first human Neuralink system Sunday and is said to be recovering well. It received FDA permission to begin human trials back in May, and the company began recruiting patients in the fall.

First Edition: Jan. 30, 2024

January 30, 2024 Morning Briefing

Today’s early morning highlights from the major news organizations.

Where Are the Nation’s Primary Care Providers? It’s Not an Easy Answer

By Rae Ellen Bichell January 30, 2024 KFF Health News Original

Politicians keep talking about fixing primary care shortages. But flawed national data leaves big holes in how to evaluate which policies are effective.

An Arm and a Leg: Self-Defense 101: Keeping Your Cool While You Fight

By Dan Weissmann January 30, 2024 Podcast

On this episode of “An Arm and a Leg,” host Dan Weissmann seeks advice for fighting unfair medical bills from an unexpected source: an expert in self-defense.

Viewpoints: What’s Driving The New Covid Vaccine Hesitancy?; Project 2025 Would Outlaw Mifepristone

January 29, 2024 Morning Briefing

Editorial writers discuss vaccine hesitancy, reproductive health care, telehealth, and more.

CDC Study Links Pet Bearded Dragons To Salmonella Cases

January 29, 2024 Morning Briefing

Some of the exotic pets were likely obtained from the same breeder in Southeast Asia, The New York Times reports. In other news: Navy shipyard workers’ exposure to cancer-causing radioactive materials; rising freight train accidents; lead in Stanley cups; and more.

After Slashing Its Price, Novo Nordisk Discontinues Levemir Insulin In US

January 29, 2024 Morning Briefing

Last March, Novo reduced the list price of Levemir by 65%, but USA Today says that American diabetes patients who’ve benefited from this price drop (and other price caps) are set to be disappointed because the drug is being withdrawn from sale. Novo has not said it will do so in other countries.

Texas Democrats Align On Abortion As They Battle To Unseat GOP’s Ted Cruz

January 29, 2024 Morning Briefing

Democratic challengers to Sen. Ted Cruz are trying to earn the support of organized labor advocates, with abortion, guns, and border issues central to their efforts, the Austin American-Statesman says. NPR also reports that House Democratic candidates are focusing on abortion in their campaigns.

Texas AG Presses A Georgia Clinic For Medical Records Of Texas Trans Youth

January 29, 2024 Morning Briefing

This is the second time Texas Attorney General Ken Paxton is requesting private records of Texas transgender children who received gender care in another state, the Texas Tribune says. Also in the news: The VA hasn’t lived up to its gender care promises; religious trauma in LGBTQ+ Americans; and more.

Infectious-Disease Experts Say WHO’s Covid Guidelines Could Harm People

January 29, 2024 Morning Briefing

Health experts told CIDRAP that the new guidelines that are meant to protect health care workers and patients might actually put them at risk. For example, they said, the guidelines “suggest using symptoms to screen people” despite current knowledge about asymptomatic transmission. The guidelines also still adhere to “droplet dogma” instead of airborne spread, they said, and do not fully acknowledge that N95 respirators offer better protection than surgical masks.

Jury Hands Down $2.25 Billion Verdict In Bayer Roundup Cancer Case

January 29, 2024 Morning Briefing

Separately, health tech company Philips will not sell new sleep apnea devices in the U.S. as it works to comply with an FDA settlement. Also: The FDA approved Dupixent to treat younger children with allergic esophagus inflammation; the U.K. will ban disposable vapes; and more.

Chicago-Based IMX Becomes First Health Care Futures Exchange

January 29, 2024 Morning Briefing

Trading is expected to begin in the first half of 2024, Crain’s Chicago Business reports. Meanwhile, Penn Medicine abandoned plans to purchase Tower Health’s Brandywine Hospital; the White House AI Council meets today; an AI-designed drug for inflammatory bowel disease enters trials; more.

Morning Briefing for Monday, January 29, 2024

January 29, 2024 Morning Briefing

Filter Results

More From KFF Health News